Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Rafarma Pharmaceutical Discloses Recent Partnerships With Kelun Lifesciences (Pvt) Ltd in Sri Lanka and El Salvador University

Tuesday, December 12, 2023

Rafarma Pharmaceuticals is excited to announce a preliminary agreement with Kelun Lifesciences Pvt Ltd a pharmaceutical company based in Sri Lanka signed

Mabwell's Nectin-4 ADC Approved for Phase III Trial by CDE

Tuesday, December 12, 2023

Mabwell an innovative biopharmaceutical company with a comprehensive industry chain has obtained approval from the Center for Drug Evaluation of the National Medical Products Administration for its submission This submission pertains

NMPA Grants Approval for Sugemalimab as First-line Treatment for Esophageal Squamous Cell Carcinoma, as Announced by CStone

Monday, December 11, 2023

CStone Pharmaceuticals a prominent biopharmaceutical company specializing in innovative immunooncology therapies has received approval from the National Medical Products Administration

Rigel Pharmaceuticals and MD Anderson Establish Strategic Collaboration to Progress REZLIDHIA® (Olutasidenib) in AML and Other Cancer Forms

Saturday, December 09, 2023

Rigel Pharmaceuticals Inc and The University of Texas MD Anderson Cancer Center have recently revealed a strategic development collaboration spanning multiple years to extend the assessment of REZLIDHIA

Innovent Biologics and Synaffix Broaden ADC Collaboration After Positive Initial Clinical Signals From Ongoing Phase 1 Study

Friday, December 08, 2023

Innovent Biologics Inc a prominent biopharmaceutical company specializing in the development manufacturing and commercialization of highquality medicines for various medical conditions

FDA Approves Avzivi® (bevacizumab-tnjn), a Biosimilar Referencing Avastin®, Developed by Bio-Thera Solutions

Friday, December 08, 2023

BioThera Solutions Ltd has announced that the United States Food and Drug Administration has given the green light for Avzivi bevacizumabtnjn a biosimilar referencing Avastin

Abelzeta Pharma and Astrazeneca Announce Collaboration for the Joint Development of an Original Glypican 3 (GPC3) Armored CAR-T Therapy in China

Friday, December 08, 2023

AbelZeta Pharma Inc a global clinicalstage biopharmaceutical company specializing in innovative cell therapies for cancer inflammatory and immunological diseases has recently announced a partnership with AstraZeneca

Antengene Receives Regulatory Approval in Macau for XPOVIO® in the Treatment of Relapsed and/or Refractory Multiple Myeloma

Thursday, December 07, 2023

Antengene Corporation Limited listed as SEHK HK a renowned global biopharmaceutical company specializing in innovative therapies for hematology and oncology has obtained approval from the Pharmaceutical

Ractigen Therapeutics Advances to Clinical Stage with Revolutionary saRNA Medication, RAG-01

Thursday, December 07, 2023

Ractigen Therapeutics a prominent player in the realm of small activating RNA therapeutics is pleased to announce the submission of a clinical trial application in Australia This significant move sets the stage for a phase I

Synplogen and Ginkgo Bioworks Announce Collaborative Efforts to Boost Worldwide DNA Manufacturing and Gene Therapy Platform Services in Japan

Thursday, December 07, 2023

Synplogen Co a synthetic biology startup emerging from Kobe Universitys Graduate School of Science Technology and Innovation is set to collaborate with Ginkgo Bioworks a company at the forefront of developing